Published in

Oxford University Press, Open Forum Infectious Diseases, 2024

DOI: 10.1093/ofid/ofae158

Links

Tools

Export citation

Search in Google Scholar

An Unexpectedly High Incidence of Invasive Fungal Diseases in Solid Organ Transplant Recipients on Belatacept for Organ Rejection Prophylaxis: A Single Center Retrospective Cohort Study

Journal article published in 2024 by Elizabeth Bell ORCID, Jennifer Pisano, Manasa Brown, Daniel Friedman ORCID
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
White circle
Published version: policy unclear
Data provided by SHERPA/RoMEO

Abstract

Abstract 15% of solid organ transplant recipients on belatacept developed invasive fungal diseases (IFD). The most common IFD were aspergillosis (56%) and candidiasis (22%). The infected cohort was more likely to receive basiliximab, lung transplantation, or identify as White. Higher rates of aspergillosis were seen in this lung cohort than previously reported.